Biotest Aktiengesellschaft Total Liabilities

Latest as of March 2025: €906.90 Million EUR ≈ $1.06 Billion USD

Biotest Aktiengesellschaft total liabilities. Based on the latest financial reports, Biotest Aktiengesellschaft (BIO3) has total liabilities worth €906.90 Million EUR (≈ $1.06 Billion USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Biotest Aktiengesellschaft asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Biotest Aktiengesellschaft (2002–2024)

Total liabilities of Biotest Aktiengesellschaft from 2002 to 2024. This chart illustrates how Biotest Aktiengesellschaft's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Biotest Aktiengesellschaft's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Biotest Aktiengesellschaft Competitors by Total Liabilities

The table below lists competitors of Biotest Aktiengesellschaft ranked by their total liabilities.

Company	Country	Total Liabilities
IRESS LTD F:BRF	Germany	€246.29 Million
COMPASS PATHW SP.ADR F:5Y6	Germany	€420.03 Million
Thermador Groupe SA PA:THEP	France	€165.22 Million
Liberty Broadband Srs A NASDAQ:LBRDA	USA	$1.94 Billion
Chapters Group AG XETRA:CHG	Germany	€306.36 Million
Tianyang Hot Mel SHG:603330	China	CN¥872.42 Million
Mako Mining Corp Common Stock NASDAQ:MAKO	USA	$106.11 Million
Changzhou Tronly New Electronic Materials Co Ltd SHE:300429	China	CN¥1.55 Billion

Liability Composition Analysis (2002–2024)

This chart breaks down Biotest Aktiengesellschaft's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see BIO3 total assets.

Liquidity & Leverage Metrics

Biotest Aktiengesellschaft Total Liabilities Ratios Explained

Biotest Aktiengesellschaft total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	4.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.78	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.64	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biotest Aktiengesellschaft's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biotest Aktiengesellschaft (2002–2024)

The table below shows the annual total liabilities of Biotest Aktiengesellschaft from 2002 to 2024.

Year	Total Liabilities	Change
2024-12-31	€903.30 Million ≈ $1.06 Billion	-0.95%
2023-12-31	€912.00 Million ≈ $1.07 Billion	+9.63%
2022-12-31	€831.90 Million ≈ $972.58 Million	+14.94%
2021-12-31	€723.80 Million ≈ $846.20 Million	+4.94%
2020-12-31	€689.70 Million ≈ $806.33 Million	+9.22%
2019-12-31	€631.50 Million ≈ $738.29 Million	+15.43%
2018-12-31	€547.10 Million ≈ $639.62 Million	-13.26%
2017-12-31	€630.70 Million ≈ $737.35 Million	+10.24%
2016-12-31	€572.10 Million ≈ $668.85 Million	+3.94%
2015-12-31	€550.40 Million ≈ $643.48 Million	-0.36%
2014-12-31	€552.40 Million ≈ $645.81 Million	+29.73%
2013-12-31	€425.80 Million ≈ $497.80 Million	+36.08%
2012-12-31	€312.91 Million ≈ $365.83 Million	-6.90%
2011-12-31	€336.09 Million ≈ $392.93 Million	+3.50%
2010-12-31	€324.73 Million ≈ $379.64 Million	-10.69%
2009-12-31	€363.59 Million ≈ $425.08 Million	+7.36%
2008-12-31	€338.67 Million ≈ $395.94 Million	+8.92%
2007-12-31	€310.94 Million ≈ $363.52 Million	+59.71%
2006-12-31	€194.69 Million ≈ $227.62 Million	-1.73%
2005-12-31	€198.12 Million ≈ $231.63 Million	-20.85%
2004-12-31	€250.31 Million ≈ $292.64 Million	+1.47%
2003-12-31	€246.69 Million ≈ $288.41 Million	-5.55%
2002-12-31	€261.20 Million ≈ $305.37 Million	--

About Biotest Aktiengesellschaft

XETRA:BIO3 Germany

Market Cap

$656.94 Million

€561.91 Million EUR

Market Cap Rank

#10555 Global

#1254 in Germany

Share Price

€28.40

Change (1 day)

+0.00%

52-Week Range

€28.40 - €28.40

All Time High

€43.69